# Phase IIa Safety and Efficacy Study of SRD174 Cream in Patients With AD-associated Pruritus

> **NCT00838708** · PHASE2 · COMPLETED · sponsor: **Serentis Ltd.** · enrollment: 62 (actual)

## Conditions studied

- Pruritus, Atopic Dermatitis

## Interventions

- **DRUG:** SRD174 Cream
- **OTHER:** vehicle cream

## Key facts

- **NCT ID:** NCT00838708
- **Lead sponsor:** Serentis Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-07
- **Final completion:** 2009-08
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2009-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00838708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00838708, "Phase IIa Safety and Efficacy Study of SRD174 Cream in Patients With AD-associated Pruritus". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00838708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*